Affitech announces Management change
September 30, 2011 03:15 ET
|
Affitech A/S
Copenhagen and Oslo, 30th September, 2011, 2011-09-30 09:15 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, today announced that Dr Martin Welschof, its...
Affitech meddeler ændring i Direktionen
September 30, 2011 03:15 ET
|
Affitech A/S
København og Oslo, 30. September 2011, 2011-09-30 09:15 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag, at Martin Welschof,...
Affitech A/S reports progress in development of its fully human antibody drug programs AT001 and AT008 and financial result for the second quarter of 2011
August 31, 2011 11:00 ET
|
Affitech A/S
Copenhagen and Oslo, 31st August, 2011, 2011-08-31 17:00 CEST (GLOBE NEWSWIRE) --
First payment of DKK 18.6m received under Russian strategic alliance
AT001/r84 GMP manufacturing...
Affitech A/S rapporterer fremgang i udviklingen af Selskabets 100% humane antistof lægemiddelprogrammer AT001 og AT008 og finansielt resultat for andet kvartal af 2011
August 31, 2011 11:00 ET
|
Affitech A/S
København og Oslo, d. 31. august 2011, 2011-08-31 17:00 CEST (GLOBE NEWSWIRE) --
Affitech modtog første betaling på 18,6 millioner kr. som led i strategisk russisk samarbejde
GMP produktion...
Revised financial calendar 2011
August 25, 2011 10:13 ET
|
Affitech A/S
Copenhagen and Oslo, 25th August, 2011, 2011-08-25 16:13 CEST (GLOBE NEWSWIRE) --
Release no...
Storaktionærmeddelelse - Krosalter Enterprises Ltd.
July 14, 2011 02:20 ET
|
Affitech A/S
København og Oslo, 14. juli 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler, at Krosalter Enterprises Ltd. Cypern d. 13....
Major shareholder announcement - Krosalter Enterprises Ltd.
July 14, 2011 02:20 ET
|
Affitech A/S
Copenhagen and Oslo, 14th July, 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today, that Krosalter Enterprises Ltd....
Storaktionærmeddelelse - Transnova Investments Ltd.
July 14, 2011 02:20 ET
|
Affitech A/S
København og Oslo, 14. juli 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i henhold til værdipapirlovens §29 og...
Major shareholder announcement - Transnova Investments Ltd.
July 14, 2011 02:20 ET
|
Affitech A/S
Copenhagen and Oslo, 14th July, 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today according to the Danish...